Lebenslauf Priv.-Doz. DDr.
Raffaella Calabretta, MD
Auf dieser Seite finden Sie den Lebenslauf, erreichte Meilensteine und Mitgliedschaften von Priv.-Doz. DDr. Raffaella Calabretta, MD
Priv.-Doz. DDr. Raffaella Calabretta, MD
Priv.-Doz. DDr. Raffaella Calabretta, MD
Specialist in Nuclear Medicine
Division of Nuclear Medicine
Department of Biomedical Imaging and Image-guided Therapy
Medical University of Vienna
Vienna, Austria
Areas of Interest:
Nuclear Medicine, Nuclear Cardiology and Cardiovascular Imaging, Cardio-Oncology
Aktuell
Oberärztin an der Klinischen Abteilung für Nuklearmedizin, Universitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien
• Bereichsleiterin der Szintigraphieambulanz
• Leiterin der Nuklearkardiologie
Forschung & Lehrtätigkeit an der Medizinischen Universität Wien
2023
Doctoral Degree - Doctoral Programme in Applied Medical Sciences on “Cardiovascular and pulmonary Disease” - Medical University of Vienna
2023
Habilitation and acquisition of the degree “Privatdozentin – Priv.-Doz.” at the Medical University of Vienna
2023
Habilitation im Fach Nuklearmedizin an der Medizinischen Universität Wien - Titel der Arbeit: „Molekulare Bildgebung atherosklerotischer Erkrankungen“
2020 - 2023
Doktorats-Studium (Doctoral Programme in Applied Medical Sciences on “Cardiovascular and pulmonary Disease”) an der Medizinischen Universität Wien
2018
Specialist in Nuclear Medicine - University of Florence
2013 - 2018
Facharztausbildung an der Klinischen Abteilung für Nuklearmedizin, Department of Experimental and Clinical Biomedical Sciences "Mario Serio, Universität Florenz (Italien)
2012
MD Degree - University of Florence
2006 – 2012
Studium der Humanmedizin an der Universität Florenz (Italien)
Work and Science Experience:
- Council of Cardio-Oncology Member – ESC (European Society of Cardiology)
- Member of Nuclear Cardiology Sub-Committee of EACVI Certification Board – ESC Member of GICN (Gruppo Italiano di Cardiologia Nucleare)
- Head Nuclear Cardiology – Division of Nuclear Medicine, Department of Biochemical Imaging and Image-guided Therapy, Medical University of Vienna
- Section Head Scintigraphy Outpatient Clinic – Division of Nuclear Medicine, Department of Biochemical Imaging and Image-guided Therapy, Medical University of Vienna
- Teaching and Educucation at Medical University of Vienna
ORCID: 0000000280183884
Selected Publications:
- Spielvogel CP, Lazarevic A, Zisser L, Haberl D, Eseroglou C, Beer L, Hacker M, Calabretta R. Artificial intelligence-enabled opportunistic identification of immune checkpoint inhibitor-related adverse events using [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2025 May 29. DOI: 1007/s00259-025-07364-2
- Rettl R, Duca F, Kronberger C, Binder C, Willixhofer R, Ermolaev N, Poledniczek M, Hofer F, Nitsche C, Hengstenberg C, Eslam RB, Kastner J, Bergler-Klein J, Hacker M, Calabretta R, Kammerlander AA. Prognostic implication of DPD quantification in transthyretin cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2025 Jan 31;26(2):251-260. DOI: 1093/ehjci/jeae295
- Calabretta R, Kokomani A, Fumagalli C, Olivotto I, Camici PG, Hacker M, Sciagrà R. Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy. J Nucl Cardiol. 2022 Aug;29(4):1946-1951. Epub 2022 Feb 2. Erratum in: J Nucl Cardiol. 2022 Feb 22. DOI: 1007/s12350-022-02911-y
- Calabretta R, Castello A, Giglioli C, Cecchi E, Cerisano G, Hacker M, Sciagrà R. Prognostic value of divergent pattern detection by 99mTc-sestamibi gated SPECT in patients with anterior acute myocardial infarction. J Nucl Cardiol. 2022 Dec;29(6):3115-3122. DOI: 1007/s12350-021-02874-6
- Calabretta R, Hoeller C, Pichler V, Mitterhauser M, Karanikas G, Haug A, Li X, Hacker M. Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries. Circulation. 2020 Dec 15;142(24):2396-2398. Epub 2020 Sep 8. DOI: 1161/circulationaha.120.048708
